Martin Kohl is a medical writer based in Bronx, New York.
High Tech = High Cost
Increased paperwork is at least partly to blame for many of the management difficulties faced by dermatologists, according to Thomas G. Olsen M.D.
Switching Gears in Atopic Dermatitis: How Upadacitinib Helps Patients Reach Optimal Targets After Dupilumab Inadequacy
Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial
Abrocitinib Shows Age-Linked Safety Differences
#DermTok: Navigating TikTok’s Acne Advice Misinformation